JJ

Jayaraman Janarthanam

Active Director Director DIN 11157928
DIN 11157928 First appointment Jun 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayaraman Janarthanam

Data last updated:

Jayaraman Janarthanam is a Director at Sri Mookambika Biotech Private Limited (since 2025). The company operates in Biotechnology.

DIN 11157928
Primary Designation Director
Industry Biotechnology
First Appointment 17 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jun 20252025Active

Board colleagues of Jayaraman Janarthanam

Directorship timeline

Open interactive timeline →
Sri Mookambika Biotech Private Limited
Premium access

Shareholding and investment profile for Jayaraman Janarthanam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayaraman Janarthanam

Jayaraman Janarthanam currently holds 1 directorship: Sri Mookambika Biotech Private Limited (Director, since 17 Jun 2025).

Jayaraman Janarthanam was first appointed on 17 Jun 2025 as Director at Sri Mookambika Biotech Private Limited.

The current boards of Jayaraman Janarthanam's companies include Subashini (Sri Mookambika Biotech Private Limited), Vadivelu Ganapathi (Sri Mookambika Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available